% | $
Quotes you view appear here for quick access.

Keryx Biopharmaceuticals Inc. Message Board

  • clsnphase3 clsnphase3 Sep 12, 2012 10:08 AM Flag

    CLSN could be a $30 name in 2013

    Liver, and potential use in Breast & Lung Cancer treatment.

    This market cap should be MUCH higher. I know it's had a good quarter, but the fact of the matter is CLSN should never have lived in the $2-$3 range.

    Thermodox is smacking these tumors in a GOOD way. HEAT Trials/Data should show this.

    I'm absolutely floored that very little realize the potential here. This is not an efficient market IMO. Revenues could be 1-2B annually.

    Do your DD ; Shorts are trying to stop this advance but I believe institutions will buy any dip. Don't get stopped. This stock is going much higher.

    Sentiment: Strong Buy

7.42-0.09(-1.20%)Jul 22 4:00 PMEDT